Novabay Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)1holders −13
0new positions
14sold out
$0.11avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings, down 13 from Q1 2024. 0 opened new positions and 14 sold out. The largest holder was Blue Trust, Inc. ($4).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P300
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 14 | $46K |
All 13F filers, Q1 2024 → Q2 2024: 434,286 shares sold, net −434,286 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Blue Trust, Inc. | 0.00% | No change | 37 | $4 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.